Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.
Room3906 Jinmao Tower, 88 Century Boulevard, Shanghai 200121, China
Zhang Ao
Executive Director
Artavazd Arumov Ph.D
Principal
Cyrus Chan
Associate
Nan Chen
Principal
David Chu
Partner
Phil DiGiacomo
Principal
Anna French
Managing Partner
Yuxin Fu
Vice President
Jinda Gao
Principal
Kuantai Yeh
Partner
Robert Headley
Partner
Maykin Ho
Venture Partner
William Hu
Managing Partner
Duane Kuang
Co-Founder and Managing Partner
Nisa Leung
Managing Partner
Dingzheng Li
Vice President
Jing Liu
Vice President
Chang Liu
Associate
Bin Liu
Vice President
Biao Lu
Associate
Shuo Mao
Principal
Will McConnell
Principal
Gary Rieschel
Founder and Managing Partner
James Shen
Venture Partner
Motao Sun
Vice President
Amy Tang
Venture Partner
Yi Tang
Principal
Shiyu Wang
Partner
Rachel Wang
Venture Partner
James Wang
Venture Partner
Jing Wu
Partner
Gillian Xu
RMB funds CFO
Peter (Ming) Yin
Principal, Cleantech
Janet Yu
Partner
Oscar Zhang
Principal
Yafeng Zhou
Associate
Alex Zhou
Partner
Zhiyuan Zhou
Associate
Zhifeng Zhou
Managing Partner
Jing-Shan Hu Ph.D
Venture Partner of Healthcare
Phillip DiGiacomo Ph.D
Principal
Past deals in Embedded Software
Force Inspiration
Angel Round in 2025
Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robot manufacturing and sales.
Inexbot
Series A in 2023
iNexBot specializes in the development and manufacturing of robot motion controllers and industrial robot intelligence technology. The company focuses on creating solutions for various sectors, including industrial robotics, collaborative robotics, semiconductors, healthcare automation, and automotive electronics. iNexBot's offerings encompass advanced robot motion control systems, machine vision technology, laser seam tracking technology, and other essential robot hardware. By providing both hardware and software, iNexBot equips robot manufacturers with the necessary tools to enhance their robotic products and improve operational efficiency across multiple industries.
CIX Technology
Series A in 2023
CIX Technology specializes in developing advanced intelligent computing solutions, focusing on high-performance, energy-efficient general-purpose computing chips and CPUs. Utilizing ARM architecture, the company designs its products for a variety of applications, including notebooks, desktops, high-end tablets, and augmented/virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to create more efficient electronics and other technological products, ultimately improving computing speed and performance across various sectors.
Bitworx
Series A in 2022
Bitworx is a company based in Chengdu, China, specializing in product development and applications that leverage advanced algorithm and chip technology for communication, sensing, and detection. Currently, Bitworx is operating in stealth mode, which indicates that it is in the early stages of its business activities and may not yet be publicly disclosing its specific projects or technologies. The focus on communication and sensing technologies suggests a commitment to innovation in fields that require precise detection and data transmission capabilities.
CIX Technology
Seed Round in 2022
CIX Technology specializes in developing advanced intelligent computing solutions, focusing on high-performance, energy-efficient general-purpose computing chips and CPUs. Utilizing ARM architecture, the company designs its products for a variety of applications, including notebooks, desktops, high-end tablets, and augmented/virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to create more efficient electronics and other technological products, ultimately improving computing speed and performance across various sectors.
CIX Technology
Angel Round in 2022
CIX Technology specializes in developing advanced intelligent computing solutions, focusing on high-performance, energy-efficient general-purpose computing chips and CPUs. Utilizing ARM architecture, the company designs its products for a variety of applications, including notebooks, desktops, high-end tablets, and augmented/virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to create more efficient electronics and other technological products, ultimately improving computing speed and performance across various sectors.
Element Science
Series C in 2020
Element Science, Inc. is a medical device and digital health company focused on developing solutions for high-risk cardiovascular patients. The company's flagship product is a patch-based wearable cardioverter defibrillator that continuously monitors heart activity to protect against sudden cardiac death. This device integrates advanced data science and machine learning algorithms with strict electromechanical medical device standards, creating a proprietary digital platform that enhances patient care as individuals transition from hospital to home. Founded in 2011 and headquartered in San Francisco, California, Element Science aims to address critical health needs and reduce hospitalization rates associated with heart disease. The company was previously known as Revive Defibrillation Systems, Inc. before adopting its current name in 2014.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.